GENE ONLINE|News &
Opinion
Blog

2021-04-19| Technology

Towards Exosome-Based Theranostics for Alzheimer’s Disease

by GeneOnline
Share To
With high biocompatibility combined with the ability to pass through BBB and carry drug payloads, exosomes have huge potential in treating AD.

Exosomes by themselves or as vehicles for drug delivery offer a Trojan horse strategy that could be exploited for treatments. In summary, the utilization of exosomes as novel theranostics offers hope in treating a devastating disease like AD.

GO Prime with only $1.49 now

LATEST
Study Reveals Healthcare Providers Face Challenges in Prescribing Pancreatic Enzyme Replacement Therapy
2026-01-13
Research Explores Evaluation Frameworks for AI Scribing Technology in Healthcare
2026-01-13
Disposable Biosensor Developed to Rapidly Detect Multiple Respiratory Viruses
2026-01-13
Researchers Develop Label-Free SPR Method for Detecting Cardiac Troponin I in Assessing Myocardial Injuries
2026-01-13
Nigerian Polyherbal Formulations Found Effective Against Antibiotic-Resistant Microorganisms
2026-01-13
Study Identifies Roles of CD46 and CD55 in Acute Lymphocytic and Myelogenous Leukemia
2026-01-13
Jubilant Biosys Opens New Noida Facility to Double Early Chemistry Scale-Up Capacity
2026-01-13
EVENT
2026-01-12
J.P. Morgan Healthcare Conference
San Francisco, California
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
Scroll to Top